|
Thoratec Initiates SHIELD II Clinical Study for HeartMate PHP
Nasdaq recently announced the start of patient enrollment in the SHIELD II U.S. Canada Goose Snow Mantra clinical trial, Canada Goose Chilliwack Bomber which aims at exploring the use of HeartMate PHP in patients undergoing high-risk percutaneous coronary intervention (PCI). |
